Collaboration, Not Calculation: A Qualitative Study of How Hospital Executives Value Hospital Medicine Groups.


Journal

Journal of hospital medicine
ISSN: 1553-5606
Titre abrégé: J Hosp Med
Pays: United States
ID NLM: 101271025

Informations de publication

Date de publication:
01 11 2019
Historique:
entrez: 25 7 2019
pubmed: 25 7 2019
medline: 21 10 2020
Statut: ppublish

Résumé

Hospital medicine groups (HMGs) typically receive financial support from hospitals. Determining a fair amount of financial support requires negotiation between HMG and hospital leaders. As the hospital medicine care model evolves, hospital leaders may regularly challenge HMGs to demonstrate the financial value of activities that do not directly generate revenue. To describe current attitudes and beliefs of hospital executives regarding the value of contributions made by HMGs. Thematic content analysis of key informant interviews. Twenty-four healthcare institutional leaders, including hospital presidents, chief medical officers, chief executive officers, and chief financial officers. Participants comprised a diverse sample from all regions in the United States, including rural, suburban, and urban locations, and academic and nonacademic institutions. Executives highly valued hospitalist groups that demonstrate alignment with hospital priorities, and often used this concept to summarize the HMG's success across several value domains. Most executives evaluated only a few key HMG metrics, but almost no executives reported calculating the HMG return on investment by summing pertinent quantitative contributions. Respondents described an evolving concept of hospitalist value and believed that HMGs generate substantial value that is difficult to measure financially. Hospital executives appear to make financial support decisions based on a small number of basic financial or care quality metrics combined with a subjective assessment of the HMG's broader alignment with hospital priorities. HMG leaders should focus on building relationships that facilitate dialog about alignment with hospital needs.

Sections du résumé

BACKGROUND
Hospital medicine groups (HMGs) typically receive financial support from hospitals. Determining a fair amount of financial support requires negotiation between HMG and hospital leaders. As the hospital medicine care model evolves, hospital leaders may regularly challenge HMGs to demonstrate the financial value of activities that do not directly generate revenue.
OBJECTIVE
To describe current attitudes and beliefs of hospital executives regarding the value of contributions made by HMGs.
DESIGN
Thematic content analysis of key informant interviews.
PARTICIPANTS
Twenty-four healthcare institutional leaders, including hospital presidents, chief medical officers, chief executive officers, and chief financial officers. Participants comprised a diverse sample from all regions in the United States, including rural, suburban, and urban locations, and academic and nonacademic institutions.
RESULTS
Executives highly valued hospitalist groups that demonstrate alignment with hospital priorities, and often used this concept to summarize the HMG's success across several value domains. Most executives evaluated only a few key HMG metrics, but almost no executives reported calculating the HMG return on investment by summing pertinent quantitative contributions. Respondents described an evolving concept of hospitalist value and believed that HMGs generate substantial value that is difficult to measure financially.
CONCLUSIONS
Hospital executives appear to make financial support decisions based on a small number of basic financial or care quality metrics combined with a subjective assessment of the HMG's broader alignment with hospital priorities. HMG leaders should focus on building relationships that facilitate dialog about alignment with hospital needs.

Identifiants

pubmed: 31339842
pii: jhm.3249
doi: 10.12788/jhm.3249
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

662-667

Auteurs

Andrew A White (AA)

Department of Medicine, University of Washington School of Medicine, Seattle, Washington.

Thomas McIlraith (T)

Mercy Medical Group, Sacramento, California.

Anton M Chivu (AM)

Department of Medicine, University of Chicago, Chicago, Illinois.

Rachel Cyrus (R)

Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois.

Christopher Cockerham (C)

Department of Medicine, Marietta Memorial Hospital, Marietta, Ohio.

Hardik Vora (H)

Hospital Medicine Division, Riverside Regional Medical Center, Newport News, Virginia.

Patrick Vulgamore (P)

Temple Center for Population Health, Temple University Health System, Philadelphia, Pennsylvania.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH